• Profile
Close

HIV drug resistance in adults receiving early vs delayed antiretroviral therapy: HPTN 052

Journal of Acquired Immune Deficiency Syndromes Mar 23, 2018

Palumbo PJ, et al. - HIV drug resistance was evaluated in adults who received early vs delayed antiretroviral therapy (ART) in a multinational trial [HIV Prevention Trials Network (HPTN) 052, enrollment 2005–2010]. Findings revealed a low frequency of new drug resistance at virologic failure in adults with early ART initiation in HPTN 052. Lower baseline viral load was identified as the main factor associated with reduced drug resistance with early ART.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay